Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

CATX stock hub

Perspective Therapeutics, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CATXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

428.7M

NYSEAMERICAN

Market data

Live price

Current market quote for this ticker.

Current price

CATX

In the news

Latest news · CATX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.6P50 18.3P75 33.7

Trailing P/En/a

P25 15P50 23.3P75 38.5

ROE-41.6

P25 -106.6P50 -46.9P75 -3.1

ROIC-28.1

P25 -63.1P50 -27.5P75 -0

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CATX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

209

Groups with data

Currency

USD

Showing 209 of 209 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000728387
Company name	Perspective Therapeutics, Inc.
Country	United States
Country code	US
Cusip	46489V302
Employees	166
Employees Change	26%
Employees Change Percent	18.57
Enterprise value	$287.2M
Exchange	NYSEAMERICAN
Financial currency	USD
First seen	2026-05-09
Industry	Medical Devices
Isin	US46489V3024
Last refreshed	2026-05-10
Market cap	$428.7M
Market cap category	Small-Cap
Price	$3.76
Price currency	USD
Rev Per Employee	5,325.3x
Sector	Healthcare
Sic	2834
Symbol	CATX
Website	https://www.perspectivetherapeutics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-24.05%
EV Sales Forward	557.5x
EV/Sales	324.91x
FCF yield	-22.21%
P/B ratio	1.35x
P/S ratio	484.96x
PS Forward	832.11x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-83.3M
Net Income	$-103.1M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-11,813.12%
Profit Per Employee	$-621,211
ROA	-23.35
ROCE	-47.66
ROE	-41.65
ROIC	-28.11

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-9.67%
Cagr15y	-6.37%
Cagr1y	60.05%
Cagr20y	-12.93%
Cagr3y	-17.06%
Cagr5y	-15.6%
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth	-39.2x
Revenue Growth Years	0x
Revenue Growth3 Y	-45.35x
Revenue Growth5 Y	-38.32x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0
Assets	$267M
Cash	$144.7M
Current Assets	$148.4M
Current Liabilities	$28.7M
Debt	$3.3M
Debt Equity	$0.02
Equity	$207M
Interest Coverage	-302
Liabilities	$59.9M
Long Term Assets	$118.6M
Long Term Liabilities	$31.3M
Net Cash	$141.5M
Net Cash By Market Cap	$33
Net Cash Growth	-36.51%
Net Debt Equity	$-0.68
Tangible Book Value	$167M
Tangible Book Value Per Share	$2.25
WACC	13.87

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.17
Net Working Capital	$-24.3M
Quick ratio	5.08
Working Capital	$119.7M
Working Capital Turnover	$0.01

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-14.57%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-63.85%
1Y total return	60%
200-day SMA	3.63
3Y total return	-42.94%
50-day SMA	4.49
50-day SMA vs 200-day SMA	50over200
5Y total return	-57.18%
All Time High	85
All Time High Change	-95.58%
All Time High Date	2005-12-15
All Time Low	1.2
All Time Low Change	213.07%
All Time Low Date	2009-03-25
ATR	0.32
Beta	1.76
Beta1y	0.93
Beta2y	1.45
Ch YTD	36.73
High	3.8
High52	6.16
High52 Date	2026-01-29
High52ch	-38.96%
Low	3.58
Low52	1.96
Low52 Date	2025-11-21
Low52ch	92.33%
Ma50ch	-16.28%
Premarket Change Percent	2.19
Premarket Price	$3.68
Premarket Volume	2,406
Price vs 200-day SMA	3.7%
RSI	40.13
RSI Monthly	46.39
RSI Weekly	48.1
Sharpe ratio	0.89x
Sortino ratio	1.75
Total Return	-14.57%
Tr YTD	36.73
Tr15y	-62.77%
Tr1m	-13.96%
Tr1w	-2.34%
Tr3m	-20.17%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	9
Analyst Count Top	1
Analyst Price Target Top	$11
Analyst Ratings	Strong Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.3
Earnings Revenue Estimate	179,744x
Earnings Revenue Estimate Growth	-47.44x
Operating Income	$-113.6M
Operating margin	-12,846.6
Price target	$12.11
Price Target Change	$222
Price Target Change Top	$193

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	74,311,293%
Float Percent	65.18%
Net Borrowing	-52,000
Shares Insiders	0.57%
Shares Institutions	30.96%
Shares Out	114,017,755
Shares Qo Q	0.06%
Shares Yo Y	14.57%
Short Float	18.4%
Short Ratio	9.72
Short Shares	11.99

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-104.2M
Average Volume	1,565,156.15x
Bv Per Share	2.78
CAPEX	$-12.7M
Ch10y	-63.85
Ch15y	-62.77
Ch1m	-13.96
Ch1w	-2.34
Ch1y	60
Ch20y	-93.73
Ch3m	-20.17
Ch3y	-42.94
Ch5y	-57.18
Ch6m	71.69
Change	4.44%
Change From Open	4.44
Close	3.6
Days Gap	0
Depreciation Amortization	3,244,000
Dollar Volume	2,989,015.8
Earnings Date	2026-05-11
Earnings Time	amc
EBIT	$-113.6M
EBITDA	$-110.3M
EPS	$-1.4
F Score	2
FCF	$-95.2M
FCF EV Yield	-33.16x
FCF Per Share	$-0.84
Financing CF	10,305,000
Fiscal Year End	December
Founded	1,983
Income Tax	$-793,000
Investing CF	41,228,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-16
Last Report Date	2025-12-31
Last Split Date	2024-06-17
Last Split Type	Reverse
Last10k Filing Date	2026-03-16
Ma150	3.65
Ma150ch	3.04%
Ma20	4.15
Ma20ch	-9.46%
Net CF	-30,951,000
Next Earnings Date	2026-05-11
Open	3.6
Optionable	Yes
Position In Range	83.72
Ppne	78,097,000
Pre Close	3.6
Price Date	2026-05-08
Ptbv Ratio	2.57
Relative Volume	0.51x
Revenue	884,000x
SBC By Revenue	1,014.25x
Share Based Comp	8,966,000
Tax By Revenue	-89.71x
Tr20y	-93.73%
Tr6m	71.69%
Us State	Washington
Volume	794,951
Z Score	-0.41

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CATX pay a dividend?

Capital-return profile for this ticker.

Performance

CATX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CATX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+31.0%

Float: +65.2% of shares outstanding

Insider ownership

+0.6%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

CATX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

40.1

Neutral momentum band

Price vs 200-day MA

+3.7%

50/200-day relationship not available

Beta (5Y)

1.76

More volatile than the market

Sharpe ratio

0.89

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CATX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current CATX stock rating?

Perspective Therapeutics, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full CATX analysis?

The full report lives at /stocks/CATX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for CATX?

The latest report frames CATX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the CATX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.